- Home
- SWTX vs MHO Comparison
SWTX vs MHO Comparison
Compare SWTX & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWTX
- MHO
- Stock Information
- Founded
- SWTX 2017
- MHO 1976
- Country
- SWTX United States
- MHO United States
- Employees
- SWTX N/A
- MHO N/A
- Industry
- SWTX Biotechnology: Pharmaceutical Preparations
- MHO Homebuilding
- Sector
- SWTX Health Care
- MHO Consumer Discretionary
- Exchange
- SWTX Nasdaq
- MHO Nasdaq
- Market Cap
- SWTX 3.0B
- MHO 3.1B
- IPO Year
- SWTX 2019
- MHO 1986
- Fundamental
- Price
- SWTX $37.92
- MHO $106.19
- Analyst Decision
- SWTX Strong Buy
- MHO Strong Buy
- Analyst Count
- SWTX 5
- MHO 3
- Target Price
- SWTX $72.40
- MHO $168.00
- AVG Volume (30 Days)
- SWTX 2.2M
- MHO 276.3K
- Earning Date
- SWTX 05-01-2025
- MHO 04-23-2025
- Dividend Yield
- SWTX N/A
- MHO N/A
- EPS Growth
- SWTX N/A
- MHO 21.59
- EPS
- SWTX N/A
- MHO 19.71
- Revenue
- SWTX $191,589,000.00
- MHO $4,504,670,000.00
- Revenue This Year
- SWTX $85.98
- MHO $7.09
- Revenue Next Year
- SWTX $69.16
- MHO $5.18
- P/E Ratio
- SWTX N/A
- MHO $5.39
- Revenue Growth
- SWTX 3417.33
- MHO 11.68
- 52 Week Low
- SWTX $28.21
- MHO $100.22
- 52 Week High
- SWTX $62.00
- MHO $176.18
- Technical
- Relative Strength Index (RSI)
- SWTX 39.33
- MHO 41.03
- Support Level
- SWTX $36.08
- MHO $102.59
- Resistance Level
- SWTX $38.77
- MHO $109.01
- Average True Range (ATR)
- SWTX 3.21
- MHO 6.03
- MACD
- SWTX -0.17
- MHO -0.41
- Stochastic Oscillator
- SWTX 36.05
- MHO 36.81
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
About MHO M/I Homes Inc.
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.